AC
GILD icon

AFAM Capital’s Gilead Sciences GILD Stock Holding History

AFAM Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$5.34M Buy
69,146
+1,145
+2% +$86.5K 0.74% 56
2018
Q2 		$4.82M Sell
68,001
-1,479
-2% -$104K 0.7% 63
2018
Q1 		$5.24M Buy
69,480
+1,571
+2% +$125K 0.58% 80
2017
Q4 		$4.87M Sell
67,909
-838
-1% -$63.6K 0.54% 90
2017
Q3 		$5.57M Buy
68,747
+1,146
+2% +$87.6K 0.67% 61
2017
Q2 		$4.79M Buy
67,601
+3,966
+6% +$264K 0.61% 73
2017
Q1 		$4.32M Buy
63,635
+4,189
+7% +$295K 0.6% 74
2016
Q4 		$4.26M Sell
59,446
-3,548
-6% -$264K 0.64% 66
2016
Q3 		$4.98M Sell
62,994
-655
-1% -$53.2K 0.8% 51
2016
Q2 		$5.31M Buy
63,649
+162
+0.3% +$14.4K 0.88% 36
2016
Q1 		$5.83M Sell
63,487
-309
-0.5% -$27.9K 0.95% 35
2015
Q4 		$6.46M Buy
63,796
+1,884
+3% +$196K 1% 31
2015
Q3 		$6.08M Buy
61,912
+4,569
+8% +$507K 0.93% 38
2015
Q2 		$6.71M Buy
57,343
+12,062
+27% +$1.32M 0.89% 39
2015
Q1 		$4.44M Buy
+45,281
New +$4.6M 0.57% 80

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AFAM Capital's GILD Position: Q3 2018 in Review

AFAM Capital increased its Gilead Sciences (GILD) stake by 1.7% in Q3 2018, buying an estimated $86.5K and bringing the position to 69,146 shares worth $5.34M. The position accounts for 0.74% of the portfolio, ranked #56.

AFAM Capital first reported a position in GILD in Q1 2015 and has held it in 15 quarters since. The position peaked at $6.71M in Q2 2015. 1,527 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

  • AFAM Capital held 69,146 shares of Gilead Sciences worth $5.34M as of Q3 2018.
  • AFAM Capital bought 1,145 Gilead Sciences shares in Q3 2018, an estimated $86.5K.
  • Gilead Sciences made up 0.74% of AFAM Capital's portfolio in Q3 2018, its #56 holding.
  • AFAM Capital first reported a position in Gilead Sciences in Q1 2015 and has held it in 15 quarters since.
  • AFAM Capital's Gilead Sciences position peaked at $6.71M in Q2 2015.
  • 1,527 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on AFAM Capital's 13F filing for Q3 2018, filed 14 Nov 2018.